BCL2L1 and neoplasm: Tumor-driven activation of the mitogen-activated protein kinase (MAPK) and AKT pathways promotes endothelin-driven astrocytic survival and upregulate the antiapoptotic genes BCL2L1, GSTA5, and TWIST1 (20).